TCL Archive Health Organizations: ACS Statement Supports funding of Research On Human Stem cells December 17, 1999
TCL Archive In Brief: House Hearing On NCI Budget Is March 16; NIH Reauthorization Sent To Senate Floor February 14, 1992
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive FCRF Contracts Hit $40.3 Million With Transfer Of Labs From NIH, Elsewhere October 8, 1982
